Skip to main content

Table 1 Clinical features of patients with classical CAH

From: Combination therapy of GnRHa, RhGH and anastrozole to improve final adult height deficit in CAH children with CPP

 

SW

SV

P

Sex (F/M)

4/6

1/5

0.33

Age of diagnosis (y)

0.2(0.1,0.3)

5.3(4.9,7.2)

< 0.001

Na+ (130–150 mmol/L)

126(124,128)

139(136,140)

0.001

K+ (3.3–5.5 mmol/L)

5.1(5.8,7.7)

4.2(3.9,4.9)

0.001

Cor (5–25 ug/dl)

2.9(1.4,3.9)

5.8(3.5,19.9)

0.019

ACTH (0–46 pg/ml)

146.6(49.8,248.6)

129.6(93.3,210.9)

0.245

17-OHP (0.3-2.0 ng/ml)

320.75(236.30,1433.00)

231.10(108.37,259.25)

0.03

T (< 10 nmol/L)

209.0(86.2,256.7)

180.7(93.4,297.5)

0.014

  1. Note: The Kruskal-Wallis test was used to analyse continuous clinical variables. Na+, sodium; K+, potassium; Cor, cortisol; ACTH, adrenocorticotropic hormone; 17-OHP, 17-hydroxyprogesterone; T, testosterone
Back to article page

BMC Pediatrics

ISSN: 1471-2431

Contact us